Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Plague is a high-consequence infectious disease with epidemic potential. The latest video in our partnership with Dr. Glaucomflecken summarizes new research evaluating ciprofloxacin versus aminoglycoside–ciprofloxacin for bubonic plague in Madagascar. 👉

NEJM's profile picture

NEJM

1,019,309 subscribers

44,943 görüntüleme • 10 ay önce •via X (Twitter)

Sağlık & İyilikBilim & Teknoloji
LIVE

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Our latest video in our partnership with Dr. Glaucomflecken summarizes new research into therapy for atrial fibrillation in patients with drug-eluting stents. Read the full study for free: nej.md/DrG36 #AFib
1:58

Our latest video in our partnership with Dr. Glaucomflecken summarizes new research into therapy for atrial fibrillation in patients with drug-eluting stents. Read the full study for free: nej.md/DrG36 #AFib

NEJM

13,414 görüntüleme • 5 ay önce

Which is better? Lactated Ringer’s solution or normal saline? The latest video in our partnership with Dr. Glaucomflecken summarizes the FLUID trial. 👉
1:27

Which is better? Lactated Ringer’s solution or normal saline? The latest video in our partnership with Dr. Glaucomflecken summarizes the FLUID trial. 👉

NEJM

87,546 görüntüleme • 11 ay önce

Could a structured exercise program after undergoing adjuvant chemotherapy for colon cancer improve survival and quality of life? The latest video in our partnership with Dr. Glaucomflecken summarizes new research. Access the article for free:
1:11

Could a structured exercise program after undergoing adjuvant chemotherapy for colon cancer improve survival and quality of life? The latest video in our partnership with Dr. Glaucomflecken summarizes new research. Access the article for free:

NEJM

71,735 görüntüleme • 1 yıl önce

“Ah, it's your first gastroenteritis. It gets easier.” The latest video in our partnership with Dr. Glaucomflecken summarizes recent research on the effects of ondansetron after emergency visits in children with gastroenteritis-associated vomiting. 👉
1:08

“Ah, it's your first gastroenteritis. It gets easier.” The latest video in our partnership with Dr. Glaucomflecken summarizes recent research on the effects of ondansetron after emergency visits in children with gastroenteritis-associated vomiting. 👉

NEJM

43,336 görüntüleme • 9 ay önce

Dude, Phil, you can’t out-study Infectious Disease. Don’t even try. Our latest video in our partnership with Dr. Glaucomflecken summarizes the AZ-SWED trial that evaluated whether a 5-day course of azithromycin decreases the severity of illness in young children with wheezing. Read the full study for free: #pediatrics
1:17

Dude, Phil, you can’t out-study Infectious Disease. Don’t even try. Our latest video in our partnership with Dr. Glaucomflecken summarizes the AZ-SWED trial that evaluated whether a 5-day course of azithromycin decreases the severity of illness in young children with wheezing. Read the full study for free: #pediatrics

NEJM

42,324 görüntüleme • 1 ay önce

Our latest video in our partnership with Dr. Glaucomflecken summarizes a new trial investigating the mass administration of ivermectin for reducing malaria transmission. Read the full results of the BOHEMIA trial for free:
1:14

Our latest video in our partnership with Dr. Glaucomflecken summarizes a new trial investigating the mass administration of ivermectin for reducing malaria transmission. Read the full results of the BOHEMIA trial for free:

NEJM

19,398 görüntüleme • 9 ay önce

Our latest video in our partnership with Dr. Glaucomflecken summarizes the POTCAST trial, which assessed a strategy of actively increasing plasma potassium levels to the high-normal range in patients at high risk for ventricular arrhythmias. Read the full study for free:
1:27

Our latest video in our partnership with Dr. Glaucomflecken summarizes the POTCAST trial, which assessed a strategy of actively increasing plasma potassium levels to the high-normal range in patients at high risk for ventricular arrhythmias. Read the full study for free:

NEJM

89,824 görüntüleme • 6 ay önce

Our partnership with Dr. Glaucomflecken continues as he summarizes new research into fracture prevention with infrequent zoledronate in women 50 to 60 years of age. Access the article for free:
1:19

Our partnership with Dr. Glaucomflecken continues as he summarizes new research into fracture prevention with infrequent zoledronate in women 50 to 60 years of age. Access the article for free:

NEJM

62,537 görüntüleme • 1 yıl önce

Our latest video in our partnership with Dr. Glaucomflecken summarizes a trial assessing the efficacy and safety of intravenous tenecteplase for acute central retinal artery occlusion. Read the full study for free:
1:17

Our latest video in our partnership with Dr. Glaucomflecken summarizes a trial assessing the efficacy and safety of intravenous tenecteplase for acute central retinal artery occlusion. Read the full study for free:

NEJM

34,611 görüntüleme • 4 ay önce

Our latest video in our partnership with Dr. Glaucomflecken summarizes the results of a trial investigating the effectiveness of shunt surgery for idiopathic normal-pressure hydrocephalus. Read the full results for free: #neurology
1:23

Our latest video in our partnership with Dr. Glaucomflecken summarizes the results of a trial investigating the effectiveness of shunt surgery for idiopathic normal-pressure hydrocephalus. Read the full results for free: #neurology

NEJM

56,763 görüntüleme • 7 ay önce

Patients with giant-cell arteritis need better treatments. This video, in partnership with Dr. Glaucomflecken, summarizes new research findings on the JAK-1 inhibitor upadacitinib in patients with giant-cell arteritis. Access the article for free:
1:28

Patients with giant-cell arteritis need better treatments. This video, in partnership with Dr. Glaucomflecken, summarizes new research findings on the JAK-1 inhibitor upadacitinib in patients with giant-cell arteritis. Access the article for free:

NEJM

92,870 görüntüleme • 1 yıl önce

Our latest video in our partnership with Dr. Glaucomflecken summarizes the final analysis of 23 years of follow-up to evaluate the long-term effects of PSA screening. Read the full analysis for free:
1:16

Our latest video in our partnership with Dr. Glaucomflecken summarizes the final analysis of 23 years of follow-up to evaluate the long-term effects of PSA screening. Read the full analysis for free:

NEJM

185,636 görüntüleme • 8 ay önce

Phil, this is the kind of question with no clear answers and dozens of opinions that internists dream of! Our latest video in our partnership with Dr. Glaucomflecken summarizes the Ez-PAVE trial that evaluated the appropriate LDL cholesterol target for secondary prevention in patients with atherosclerotic cardiovascular disease. Read the full study for free: #Cardiology
1:34

Phil, this is the kind of question with no clear answers and dozens of opinions that internists dream of! Our latest video in our partnership with Dr. Glaucomflecken summarizes the Ez-PAVE trial that evaluated the appropriate LDL cholesterol target for secondary prevention in patients with atherosclerotic cardiovascular disease. Read the full study for free: #Cardiology

NEJM

49,815 görüntüleme • 3 ay önce

For patients with generalized myasthenia gravis, existing treatments reduce mortality and alleviate symptoms, but side effects and poor efficacy leave many patients seeking alternatives. The latest video in our partnership with Dr. Glaucomflecken summarizes the MINT trial. 👉
1:40

For patients with generalized myasthenia gravis, existing treatments reduce mortality and alleviate symptoms, but side effects and poor efficacy leave many patients seeking alternatives. The latest video in our partnership with Dr. Glaucomflecken summarizes the MINT trial. 👉

NEJM

137,409 görüntüleme • 11 ay önce

In the latest video in our partnership with Dr. Glaucomflecken, the INSEMA trial investigating axillary surgery in breast cancer is explained. Access the article for free:
1:22

In the latest video in our partnership with Dr. Glaucomflecken, the INSEMA trial investigating axillary surgery in breast cancer is explained. Access the article for free:

NEJM

130,645 görüntüleme • 1 yıl önce

Our latest video in our partnership with Dr. Glaucomflecken summarizes the CORALreef Lipids trial, which assessed the efficacy of the oral PCSK9 inhibitor enlicitide in reducing LDL cholesterol levels over a 52-week period. Read the full study for free: #cardiology
1:18

Our latest video in our partnership with Dr. Glaucomflecken summarizes the CORALreef Lipids trial, which assessed the efficacy of the oral PCSK9 inhibitor enlicitide in reducing LDL cholesterol levels over a 52-week period. Read the full study for free: #cardiology

NEJM

57,009 görüntüleme • 5 ay önce

Our partnership with Dr. Glaucomflecken continues as he summarizes recent research into male-partner treatment to prevent recurrence of bacterial vaginosis. Access the article for free:
1:21

Our partnership with Dr. Glaucomflecken continues as he summarizes recent research into male-partner treatment to prevent recurrence of bacterial vaginosis. Access the article for free:

NEJM

58,559 görüntüleme • 1 yıl önce

Well, it depends... who do you want to yell at you? Cardiology or Nephrology? Our latest video in partnership with Dr. Glaucomflecken summarizes the ARISE FLUIDS trial that examined whether hemodynamic resuscitation with early vasopressors versus more liberal fluids could affect outcomes in patients with septic shock. Read the full study for free: #emergencymedicine
0:58

Well, it depends... who do you want to yell at you? Cardiology or Nephrology? Our latest video in partnership with Dr. Glaucomflecken summarizes the ARISE FLUIDS trial that examined whether hemodynamic resuscitation with early vasopressors versus more liberal fluids could affect outcomes in patients with septic shock. Read the full study for free: #emergencymedicine

NEJM

38,450 görüntüleme • 12 gün önce

Our latest video in our partnership with Dr. Glaucomflecken explores recent research into the safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite. Get free access to the article: #IDTwitter
1:47

Our latest video in our partnership with Dr. Glaucomflecken explores recent research into the safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite. Get free access to the article: #IDTwitter

NEJM

28,105 görüntüleme • 1 yıl önce

Yes! Journal club! Our latest video in partnership with Dr. Glaucomflecken summarizes the B-Well 1 and B-Well 2 trials investigating bepirovirsen therapy for chronic hepatitis B virus infection. Read the full study for free: #hepatology
1:13

Yes! Journal club! Our latest video in partnership with Dr. Glaucomflecken summarizes the B-Well 1 and B-Well 2 trials investigating bepirovirsen therapy for chronic hepatitis B virus infection. Read the full study for free: #hepatology

NEJM

32,725 görüntüleme • 1 ay önce